Rigel Pharmaceuticals Share Price Today
(NASDAQ: RIGL)

Name: Rigel Pharmaceuticals Share Price Today (NASDAQ: RIGL) - Rigel Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Rigel Pharmaceuticals share price is $16.85 & ₹1,440.09 as on 18 Apr 2025, 2.30 'hrs' IST

$16.85

▲

0.36

(2.18%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Rigel Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Rigel Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rigel Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Rigel Pharmaceuticals share price movements

Today's Low: $16.11
Today's High: $17.10
$16.85
4.39%
Downside
Day's Volatility :5.79%
Upside
1.46%
52 Weeks Low: $7.48
52 Weeks High: $29.82
$16.85
55.58%
Downside
52 Weeks Volatility :74.9%
Upside
43.49%

Rigel Pharmaceuticals (RIGL) Returns

Period	Rigel Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-22.74%	-2.8%	0.0%
6 Months	13.77%	-11.0%	0.0%
1 Year	56.02%	-1.9%	0.0%
3 Years	-38.73%	-1.5%	-12.9%

Rigel Pharmaceuticals (RIGL) Key Statistics

in dollars & INR

Previous Close	$16.49
Open	$16.39
Today's High	$17.1
Today's Low	$16.11
Market Capitalization	$301.1M
Today's Volume	$103.3K
52 Week High	$29.82
52 Week Low	$7.4843
Revenue TTM	$179.3M
EBITDA	$26.4M
Earnings Per Share (EPS)	$0.99
PE Ratio	17.02
Profit Margin	9.75%
Quarterly Earnings Growth YOY	17.87%
Return On Equity TTM	-699.05%

How to invest in Rigel Pharmaceuticals Stock (RIGL) from India?

It is very easy for Indian residents to invest directly in Rigel Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rigel Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rigel Pharmaceuticals or RIGL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rigel Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rigel Pharmaceuticals shares which would translate to 0.051 fractional shares of Rigel Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rigel Pharmaceuticals, in just a few clicks!

Returns in Rigel Pharmaceuticals (RIGL) for Indian investors in Rupees

The Rigel Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Rigel Pharmaceuticals investment value today

Current value as on today

₹1,58,360

Returns

₹58,360

(+58.36%)

Returns from Rigel Pharmaceuticals Stock

₹56,019 (+56.02%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Rigel Pharmaceuticals (RIGL)

-22%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Rigel Pharmaceuticals Stock from India on INDmoney has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Rigel Pharmaceuticals

BlackRock Inc
9.78%
Morgan Stanley - Brokerage Accounts
8.74%
Armistice Capital, LLC
6.45%
Soleus Capital Management, L.P.
6.33%
Vanguard Group Inc
5.67%
Assenagon Asset Management SA
2.30%

Analyst Recommendation on Rigel Pharmaceuticals

Rating

Trend

Buy

58%Buy

41%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Rigel Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Rigel Pharmaceuticals Stock (RIGL)

What analysts predicted

Upside of 99.8%

Target:

$33.67

Current:

$16.85

Insights on Rigel Pharmaceuticals Stock (Ticker Symbol: RIGL)

Price Movement
In the last 1 year, RIGL stock has moved up by 52.7%
Increasing Revenue
Revenue is up for the last 4 quarters, 29.53M → 57.59M (in $), with an average increase of 19.1% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -8.24M → 14.34M (in $), with an average increase of 274.1% per quarter
RIGL vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 23.4%
RIGL vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 70.8%
Price to Sales
ForRIGL every $1 of sales, investors are willing to pay $1.7, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Rigel Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Rigel Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Rigel Pharmaceuticals (RIGL) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Rigel Pharmaceuticals Inc	-19.05%	13.77%	56.02%	-38.73%	4.66%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Rigel Pharmaceuticals Inc	17.02	17.02	-0.1	1.24	-6.99	0.11	NA	0.19
Regeneron Pharmaceuticals, Inc.	14.33	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Rigel Pharmaceuticals Inc	Buy	$301.1M	4.66%	17.02	9.75%
Regeneron Pharmaceuticals, Inc.	Buy	$60.1B	-0.85%	14.33	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

About Rigel Pharmaceuticals

Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The company's commercialized products include Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; Rezlidhia, a non-intensive monotherapy to treat adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test; and GAVRETO, a once daily, small molecule, oral, kinase inhibitor for the treatment of adult patients with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC), as well as to treat adult and pediatric patients twelve years of age and older with advanced or metastatic RET fusion-positive thyroid cancer. It also develops R289, an oral interleukin receptor-associated kinases 1 and 4 (IRAK1/4) inhibitor for the treatment of hematology-oncology, autoimmune, and inflammatory diseases, as well as to treat lower-risk myelodysplastic syndrome. In addition, the company has product candidates in clinical development with partners BerGenBio ASA, Eli Lilly and Company, and Daiichi Sankyo. It has strategic development collaboration with The University of Texas MD Anderson Cancer Center for the development of Olutasidenib in AML and other hematologic cancers with IDH1mutations, as well as with collaborative network for neuro-oncology clinical trials to evaluate Olutasidenib in combination with temozolomide in patients with high-grade glioma harboring an IDH1 mutation. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California.

Organization	Rigel Pharmaceuticals
Employees	162
CEO	Mr. Raul R. Rodriguez
Industry	Health Technology

Management People of Rigel Pharmaceuticals

Name	Title
Mr. Raul R. Rodriguez	President, CEO & Director
Mr. Raymond J. Furey J.D.	Executive VP, Chief Compliance Officer, General Counsel & Corporate Secretary
Mr. David A. Santos	Executive VP & Chief Commercial Officer
Mr. Tarek Sallam	Vice President of Marketing

Important FAQs about investing in RIGL Stock from India :

What is Rigel Pharmaceuticals share price today?

Rigel Pharmaceuticals share price today stands at $16.85, Open: $16.39 ; Previous Close: $16.49 ; High: $17.10 ; Low: $16.11 ; 52 Week High: $29.82 ; 52 Week Low: $7.48.

The stock opens at $16.39, after a previous close of $16.49. The stock reached a daily high of $17.10 and a low of $16.11, with a 52-week high of $29.82 and a 52-week low of $7.48.

Can Indians buy Rigel Pharmaceuticals shares?

Yes, Indians can invest in the Rigel Pharmaceuticals (RIGL) from India.

With INDmoney, you can buy Rigel Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Rigel Pharmaceuticals at zero transaction cost.

How can I buy Rigel Pharmaceuticals shares from India?

It is very easy to buy Rigel Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rigel Pharmaceuticals (RIGL) be purchased?

Yes, you can buy fractional shares of Rigel Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Rigel Pharmaceuticals stocks?

To start investing in Rigel Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.